Preclinical Animal Telemetry Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, France, Japan - Size and Forecast 2024-2028

Published: Jan 2024 Pages: 152 SKU: IRTNTR44979

Preclinical Animal Telemetry Market 2024-2028

The global preclinical animal telemetry market size is estimated to grow by USD 21.55 million at a CAGR of 5.69% between 2023 and 2028.  

As a part of organic growth strategies, companies are increasingly focusing on new feature integration, as well as product development and launches. The launch of new products is allowing companies to remain competitive in the market by offering the latest available technologies to their customers. Additionally, companies can efficiently meet the specific demands of end-users by bringing innovative changes in their product lineup as per customers' expectations. Some of the recent product launches have been discussed below: Since 2021, the US Animal Telemetry Network (ATN) has been attempting to integrate ocean profiles obtained from animal-borne satellite telemetry tags, including the Wildlife Computers SCOUT-CTD, into the World Meteorological Organizations Global Telecommunication System. Such constant improvements and upgrades in features have brought significant differentiation in products and have helped companies lower the competition and increase product penetration. Therefore, an increase in product launches of preclinical animal telemetry is driving the market growth during the forecast period. 

Technavio has segmented the market into End-user, Type, and Geography 

  • The end-user segment is classified into industrial laboratories and CROs, academic government, and other research laboratories
  • The type  segment is classified into small animal telemetry and large animal telemetry
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Preclinical Animal Telemetry Market During the Forecast Period?

To learn more about this report, Download Report Sample

Preclinical Animal Telemetry Market Segmentation by End-user, Type and Geography Analysis

End-user Analysis

Industrial laboratories and CROs

The market share growth by the industrial laboratories and CROs segment will be significant during the forecast period. Industrial laboratories (including pharmaceutical and biotechnology companies) and CROs are among the key organizations involved in drug discovery, research, design, and development. These organizations spend a considerable number of resources and time in preclinical and clinical research for advancing new therapeutic candidates. 

Get a glance at the market contribution of various segments Download PDF Sample

The Industrial laboratories and CROs were the largest segment and were valued at USD 32.41 million in 2018. Further, the increase in patent expiries of blockbuster drugs and biologicals has led to an increased focus on R&D activities. As a result, pharmaceutical and biotechnology companies are increasingly promoting the outsourcing of clinical research to CROs. This led to the outsourcing of R&D activities for developing new formulations. To reduce the risk of adverse events during clinical trials of these new formulations, the demand for preclinical animal testing, including toxicology testing and cosmetic testing, has increased. Animal telemetry solutions are finding extensive use for collecting and analyzing a large amount of preclinical safety and efficacy data. This preclinical safety and efficacy data is required to be submitted to drug regulatory authorities before permission for further studies in humans is granted. As a result, significant demand for preclinical animal research and testing can be observed across industrial laboratories and CROs globally, which is driving the adoption of animal telemetry systems, which, in turn, will drive the growth of the market during the forecast period.

Type Analysis

Small animal telemetry

The small animal telemetry segment includes animal telemetry solutions that are used in preclinical research with small animals such as mice, rabbits, ferrets, rats, hamsters, and Guinea pigs. Small animal telemetry solutions are usually miniaturized telemetry implants that are small in size and lightweight and can be custom-configured and modified as per the research and testing requirements. Furthermore, the availability of cost-effective, minimally invasive, wireless battery charging-based, flexible telemetry systems is adding to the growing sales of small animal telemetry systems. The market is expected to witness swift growth owing to stringencies in regulations for maintaining pharmacological safety and the growing availability of funding for research related to neuroscience, cardiology, and oncology.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America dominates the global preclinical animal telemetry market, with the US and Canada as leading revenue-generating countries. Increasing growth in drug and vaccine approvals and growth in investments for drug research and development surged the demand for animal testing during preclinical studies. As a result, the demand for animal telemetry systems witnessed significant growth in the region. Furthermore, the presence of a large number of prominent players, such as BIOPAC Systems, Indus Instruments, Harvard Biosciences, Somark Innovations, TSE Systems GMBH, Starr Life Sciences Corp., and Transonic, helped in ensuring the easy availability of advanced telemetry solutions among end-users.

Furthermore, the exceptional veterinary-specific equipment offered by Mindray Animal Medical ranges from the ePM series monitors or the TM80 Vet telemetry to a central station for vital sign monitoring, the Veta 5 and WATO series anesthesia station with integrated ventilators, and the BeneFusion VP3 Vet and BeneFusion SP3 Vet fluid pumps. These products are designed to support and elevate standards in animal health care. Therefore such factors are expected to drive the regional market growth during the forecast period. 

Buy the Full Report Now

Key Preclinical Animal Telemetry Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

ADInstruments Pty Ltd.: The company offers preclinical animal telemetry for the wireless recording of a variety of biological signals in small animals under its brand Kaha Sciences.

  • ADInstruments Pty Ltd.
  • Advanced Telemetry Systems Inc.
  • BIO RESEARCH CENTER Co. Ltd.
  • BIOPAC Systems Inc.
  • Cambridge NeuroTech
  • Charles River Laboratories International Inc.
  • Ecotone Goc
  • emka TECHNOLOGIES
  • ETISENSE SAS
  • Harvard Bioscience Inc.
  • Indus Instruments, Instem Plc
  • Kent Scientific Corp.
  • Muromachi Kikai Co. Ltd.
  • Somark Innovations
  • Star Oddi hf

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Preclinical Animal Telemetry Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market research and growth analysis. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, market trends and analysis, and challenges. 

Key Preclinical Animal Telemetry Market Drivers

Increasing growth in preclinical research and testing is notably driving the market growth. The rising prevalence of diseases such as cardiovascular diseases, endocrine and metabolic disorders, cancer, and diabetes across the globe has stimulated the demand for the development of efficient and effective therapeutics. As a result, increasing market growth and trends in preclinical and clinical research activities across pharmaceutical companies and CROs can be observed. Furthermore, the competition among drug developers is high, and to gain a competitive edge, these organizations are rapidly adopting advanced and automated workflows in their routine processes.

Thus, the demand for animal telemetry systems in preclinical research has increased. These systems offer automated and real-time monitoring of the physiological activities of small and large animal models. Such capabilities are enhancing drug development studies and are ensuring the rapid development of drugs, thereby driving the adoption of animal telemetry solutions among pharmaceutical companies and CROs. Thus, such factors will drive the growth of the market during the market forecast period.

Significant Preclinical Animal Telemetry Market Trends

Growing focus on developing SEND-compatible software is an emerging trend shaping the market growth. Modifications in US FDA regulatory requirements for data submission have brought significant changes across product lines since January 2019. To overcome inconsistencies in data formats and to define standard data format for nonclinical data presentation, the US FDA has mandated the use of the Standard of Exchange of Nonclinical Data (SEND) format, which specifies a way to present nonclinical data. Further, the availability of easy report-generating capabilities in a defined SEND format allows end-users to comply with defined standards for submitting preclinical data to the US FDA quickly and without manual efforts.

As a result, the demand for software that supports SEND-compatible output has increased among end-users. Thus, the growing focus on developing SEND-compatible software will drive the growth of the global preclinical animal telemetry market during the forecast period.

Major Preclinical Animal Telemetry Market Challenges

Limitations associated with animal telemetry systems are a significant challenge hindering market growth. Animal telemetry systems are extensively used in preclinical studies as an advanced and innovative technique for physiological monitoring and data collection of animal models. However, these systems have certain technical challenges and limitations which hamper their sales. Some of the common issues are the limited battery life of telemetric implants, poor design and scalability, bandwidth-related issues, and the lack of compatibility. Furthermore, the integration of animal telemetry hardware and software into the existing systems of laboratories is another challenge. A laboratory may operate different kinds of systems, including computers and laboratory equipment, which may not be compatible with advanced offerings from vendors.

However, such laboratory settings prefer the use of conventional systems, which lowers the adoption of new and improved systems, thereby hampering the sales of new animal telemetry systems. Thus, limitations associated with animal telemetry systems will hamper the growth of the market during the forecast period.

Buy Now Full Report

Key Preclinical Animal Telemetry Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Global Preclinical Animal Telemetry Market Customer Landscape

Segment Overview

The preclinical animal telemetry market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and market growth and forecasting opportunities from 2018 to 2028. 

  • End-user Outlook
    • Industrial laboratories and CROs
    • Academic government and
    • Other research laboratories
  • Type Outlook
    • Small animal telemetry
    • Large animal telemetry
    Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina
      • Australia

Preclinical Animal Telemetry Market Scope

Report Coverage

Details

Page number

152

Base year

2023

Historic period

2018-2022

Market forecasting period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.69%

Market Growth 2024-2028

USD 21.55 million

Market structure

Fragmented

YoY growth 2023-2024(%)

4.86

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 44%

Key countries

US, UK, Germany, France, and Japan

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

ADInstruments Pty Ltd., Advanced Telemetry Systems Inc., BIO RESEARCH CENTER Co. Ltd., BIOPAC Systems Inc., Cambridge NeuroTech, Charles River Laboratories International Inc., Ecotone Goc, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Indus Instruments, Instem Plc, Kent Scientific Corp., Muromachi Kikai Co. Ltd., Somark Innovations, Star Oddi hf, Starr Life Sciences Corp., Telemetry Solutions Inc., TSE Systems GmbH, and Vivonics Preclinical Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Preclinical Animal Telemetry Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the preclinical animal telemetry market between 2024 and 2028

  • Precise estimation of the preclinical animal telemetry market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of preclinical animal telemetry market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global preclinical animal telemetry market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global preclinical animal telemetry market 2018 - 2022 ($ million)
    • 4.2 End-user Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.3 Type Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Industrial laboratories and CROs - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
    • 6.4 Academic government and other research laboratories - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Academic government and other research laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Academic government and other research laboratories - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Academic government and other research laboratories - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Academic government and other research laboratories - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by End-user
      • Exhibit 42: Market opportunity by End-user ($ million)
      • Exhibit 43: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Exhibit 44: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
    • 7.2 Comparison by Type
      • Exhibit 46: Chart on Comparison by Type
      • Exhibit 47: Data Table on Comparison by Type
    • 7.3 Small animal telemetry - Market size and forecast 2023-2028
      • Exhibit 48: Chart on Small animal telemetry - Market size and forecast 2023-2028 ($ million)
      • Exhibit 49: Data Table on Small animal telemetry - Market size and forecast 2023-2028 ($ million)
      • Exhibit 50: Chart on Small animal telemetry - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on Small animal telemetry - Year-over-year growth 2023-2028 (%)
    • 7.4 Large animal telemetry - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Large animal telemetry - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Large animal telemetry - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Large animal telemetry - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Large animal telemetry - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Type
      • Exhibit 56: Market opportunity by Type ($ million)
      • Exhibit 57: Data Table on Market opportunity by Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 UK - Market size and forecast 2023-2028
      • Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 France - Market size and forecast 2023-2028
      • Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ million)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 ADInstruments Pty Ltd.
              • Exhibit 107: ADInstruments Pty Ltd. - Overview
              • Exhibit 108: ADInstruments Pty Ltd. - Product / Service
              • Exhibit 109: ADInstruments Pty Ltd. - Key offerings
            • 12.4 BIO RESEARCH CENTER Co. Ltd.
              • Exhibit 110: BIO RESEARCH CENTER Co. Ltd. - Overview
              • Exhibit 111: BIO RESEARCH CENTER Co. Ltd. - Product / Service
              • Exhibit 112: BIO RESEARCH CENTER Co. Ltd. - Key offerings
            • 12.5 BIOPAC Systems Inc.
              • Exhibit 113: BIOPAC Systems Inc. - Overview
              • Exhibit 114: BIOPAC Systems Inc. - Product / Service
              • Exhibit 115: BIOPAC Systems Inc. - Key offerings
            • 12.6 Cambridge NeuroTech
              • Exhibit 116: Cambridge NeuroTech - Overview
              • Exhibit 117: Cambridge NeuroTech - Product / Service
              • Exhibit 118: Cambridge NeuroTech - Key offerings
            • 12.7 emka TECHNOLOGIES
              • Exhibit 119: emka TECHNOLOGIES - Overview
              • Exhibit 120: emka TECHNOLOGIES - Product / Service
              • Exhibit 121: emka TECHNOLOGIES - Key offerings
            • 12.8 ETISENSE SAS
              • Exhibit 122: ETISENSE SAS - Overview
              • Exhibit 123: ETISENSE SAS - Product / Service
              • Exhibit 124: ETISENSE SAS - Key offerings
            • 12.9 Harvard Bioscience Inc.
              • Exhibit 125: Harvard Bioscience Inc. - Overview
              • Exhibit 126: Harvard Bioscience Inc. - Product / Service
              • Exhibit 127: Harvard Bioscience Inc. - Key offerings
            • 12.10 Indus Instruments
              • Exhibit 128: Indus Instruments - Overview
              • Exhibit 129: Indus Instruments - Product / Service
              • Exhibit 130: Indus Instruments - Key offerings
            • 12.11 Instem Plc
              • Exhibit 131: Instem Plc - Overview
              • Exhibit 132: Instem Plc - Product / Service
              • Exhibit 133: Instem Plc - Key offerings
            • 12.12 Muromachi Kikai Co. Ltd.
              • Exhibit 134: Muromachi Kikai Co. Ltd. - Overview
              • Exhibit 135: Muromachi Kikai Co. Ltd. - Product / Service
              • Exhibit 136: Muromachi Kikai Co. Ltd. - Key offerings
            • 12.13 Somark Innovations
              • Exhibit 137: Somark Innovations - Overview
              • Exhibit 138: Somark Innovations - Product / Service
              • Exhibit 139: Somark Innovations - Key offerings
            • 12.14 Star Oddi hf
              • Exhibit 140: Star Oddi hf - Overview
              • Exhibit 141: Star Oddi hf - Product / Service
              • Exhibit 142: Star Oddi hf - Key offerings
            • 12.15 Starr Life Sciences Corp.
              • Exhibit 143: Starr Life Sciences Corp. - Overview
              • Exhibit 144: Starr Life Sciences Corp. - Product / Service
              • Exhibit 145: Starr Life Sciences Corp. - Key offerings
            • 12.16 TSE Systems GmbH
              • Exhibit 146: TSE Systems GmbH - Overview
              • Exhibit 147: TSE Systems GmbH - Product / Service
              • Exhibit 148: TSE Systems GmbH - Key offerings
            • 12.17 Vivonics Preclinical Ltd.
              • Exhibit 149: Vivonics Preclinical Ltd. - Overview
              • Exhibit 150: Vivonics Preclinical Ltd. - Product / Service
              • Exhibit 151: Vivonics Preclinical Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 152: Inclusions checklist
                • Exhibit 153: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 154: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 155: Research methodology
                • Exhibit 156: Validation techniques employed for market sizing
                • Exhibit 157: Information sources
              • 13.5 List of abbreviations
                • Exhibit 158: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              preclinical animal telemetry market market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis